Business
Spectral Medical Sponsors Unite for Sepsis Symposium, Chicago September 8 – 9, 2025
Company to present at session titled “Personalizing Sepsis Treatment” TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its sponsorship of the Unite for Sepsis Symposium, taking place September 8 – 9, 2025, in Chicago, Illinois. The Company also announced that Debra Foster, Clinical Consultant at Spectral Medical, will participate i
About this update from Spectral Medical Inc
[{"type":"image","alt":"Spectral Medical Inc.","displaySize":"","headline":null,"caption":"Spectral Medical Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":216,"height":57,"url":"https://media.zenfs.com/en/globenewswire.com/c8dd3eb1a9d6f690331e05a27ac7bc09"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/P6nS4JHS3nYtocpBUIsxfw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExMTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/c8dd3eb1a9d6f690331e05a27ac7bc09","width":216,"height":57}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Company to present at session titled “Personalizing Sepsis Treatment”","length":69,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":69,"olType":false},{"type":"text","content":"TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its sponsorship of the Unite for Sepsis Symposium, taking place September 8 – 9, 2025, in Chicago, Illinois. The Company also announced that Debra Foster, Clinical Consultant at Spectral Medical, will participate in a featured session during the event.","length":468,"tagName":"p"},{"type":"text","content":"Ms. Foster will contribute to the session titled “Personalizing Sepsis Treatment”, scheduled for Day 1 at 4:15 PM CT, which will highlight how individualized approaches may support earlier intervention and improved outcomes in sepsis care.","length":239,"tagName":"p"},{"type":"text","content":"The Unite for Sepsis Symposium is a unique, in-person event convening an extraordinary community of clinicians, researchers, regulators, investors, innovators, and advocates. More than a symposium, Unite for Sepsis is a collaborative movement dedicated to transforming the way sepsis is prevented, diagnosed, and treated.","length":321,"tagName":"p"},{"type":"text","content":"For more information or to register, please visit UniteforSepsis.org","length":68,"tagName":"p"},{"type":"text","content":"About Spectral ","length":14,"tagName":"p"},{"type":"text","content":"Spectral is a Phase 3 company seeking U.S. FDA approval for its unique product for the treatment of patients with septic shock, Toraymyxin™ (“PMX”). PMX is a therapeutic hemoperfusion device that removes endotoxin, which ...